← Human Trials & Peer-Reviewed Studies
Endoscopic bilateral neck exploration versus quick intraoperative parathormone assay (qPTHa) during endoscopic parathyroidectomy: A prospective randomized trial
Plain-language guide to PMID 17522920 (2008): randomized controlled trial of Parathyroid Hormone (PTH 1-84) in 20 patients.
Key Facts
- PMID
- 17522920
- Journal
- Surgical endoscopy
- Year
- 2008
- Study type
- Randomized Controlled Trial
- Authors
- Miccoli P et al. (6 authors)
- DOI
- 10.1007/s00464-007-9408-4
What This Study Did, in Plain Language
What Was Tested
The paper reports a study of Parathyroid Hormone (PTH 1-84), published as a randomized controlled trial.
This paper aims to compare endoscopic bilateral neck exploration (BE) versus focused parathyroidectomy plus qPTHa during minimally invasive video-assisted parathyroidectomy (QM).
Why It Was Studied
Quick intraoperative parathormone assay (qPTHa) during paratyroidectomy has become a standard procedure for patients with primary hyperparathyroidism (PHPT).
The endpoints of the study are the mean operative time and outcome of the surgical procedure (PTH and calcemia normalization at one and six months postoperatively).
Who Took Part
According to the abstract, 20 patients were involved.
By PubMed's age tags, the people studied were middle-aged adults, both men and women.
Forty patients with PHPT, positive to preoperative localization studies (ultrasonography evaluation and (99)Tc-MIBI scan) for a single parathyroid adenoma, were randomly allotted into two groups.
In the first group (QM), 20 patients (17 women, three men, mean age 57.6 years) underwent focused endoscopic parathyroidectomy (MIVAP tecnicque) plus qPTHa.
How the Study Was Run
The researchers set it up as a randomized study.
The patients were allocated by chance, so the Parathyroid Hormone (PTH 1-84) group and the comparison group should start out alike.
In the second group (BE) 20 patients (17 women, three men, mean age 59.6 years) underwent endoscopic parathyroidectomy plus bilateral exploration in order to check the integrity of the remaining glands.
What Was Measured
Quick intraoperative parathormone assay (qPTHa) during paratyroidectomy has become a standard procedure for patients with primary hyperparathyroidism (PHPT).
The endpoints of the study are the mean operative time and outcome of the surgical procedure (PTH and calcemia normalization at one and six months postoperatively).
Topics PubMed links to this paper include Endoscopy, Hyperparathyroidism, Primary, Intraoperative Care, Parathyroid Hormone and Parathyroidectomy.
What This Means in Plain Language
The paper is a randomized study of Parathyroid Hormone (PTH 1-84) in 20 patients.
With fewer than 40 people, it is a small study, so it is better read as an early signal for further research than as a settled answer.
Its findings take up roughly 9 sentences of the abstract and are left out here on purpose; the source paper is the place to read them.
The publication is from 2008 (Surgical endoscopy), a journal based in Germany.
More context: the Parathyroid Hormone (PTH 1-84) compound page, all human trials.
Our Notes on the Compound
Parathyroid Hormone (PTH 1-84): The 84-amino-acid hormone that raises blood calcium; full-length PTH (Natpara) has been used in hypoparathyroidism. Teriparatide is its 1-34 fragment.
Related Pages
Source: PubMed record. This explanation is written by PeptideWhiz from the public record. For research and education only. Not medical advice; no dosing information is given.